Innovative Product Portfolio Autoimmune Technologies specializes in developing fusion-inhibiting antiviral drugs and proprietary diagnostic tests for a range of autoimmune and infectious diseases, presenting opportunities for collaborations in advanced biotech solutions and diagnostic platforms.

Niche Disease Focus With a focus on conditions like lupus, fibromyalgia, Sjogren's syndrome, and Gulf War Syndrome, the company targets specialized markets that are underserved, offering potential for tailored healthcare products and diagnostics expansion.

Growing Revenue Potential Having an annual revenue between 1M and 10M, Autoimmune Technologies demonstrates a scalable growth trajectory with opportunities for strategic partnerships to accelerate product commercialization and market penetration.

Research-Driven Innovation The company's proprietary tests and assays support advanced research and diagnostics, creating opportunities for partnerships with healthcare providers, research institutions, and biotech firms seeking cutting-edge diagnostic tools.

Technology and Infrastructure Utilizing reliable hosting and server technologies like Rackspace and Apache, Autoimmune Technologies is positioned with a solid technological backbone, enabling scalable development and deployment of new diagnostic and biotech solutions.